IgA-Type Enterovirus Antibodies Are Increased among Adults and Children with Recently Diagnosed Type 1 Diabetes.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2022
Historique:
received: 23 12 2021
accepted: 15 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 16 8 2022
Statut: epublish

Résumé

Enteroviruses (EV) are among the leading environmental triggers of childhood-onset type 1 diabetes (T1D). Our aim was to determine the prevalence of antibodies against EV and their association with T1D in different age groups (

Identifiants

pubmed: 35958821
doi: 10.1155/2022/7603062
pmc: PMC9357813
doi:

Substances chimiques

Antibodies, Viral 0
Antigens, Viral 0
Autoantibodies 0
Immunoglobulin A 0
Immunoglobulin G 0
Immunoglobulin M 0
PTPN22 protein, human EC 3.1.3.48
Protein Tyrosine Phosphatase, Non-Receptor Type 22 EC 3.1.3.48

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7603062

Informations de copyright

Copyright © 2022 Kristi Alnek et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this paper.

Références

Semin Pediatr Infect Dis. 2002 Jan;13(1):40-7
pubmed: 12118843
Sci Data. 2020 Oct 15;7(1):329
pubmed: 33057040
Nat Rev Endocrinol. 2010 May;6(5):279-89
pubmed: 20351698
Diabetologia. 2001 Jul;44(7):818-23
pubmed: 11508265
Diabetologia. 2005 Feb;48(2):290-3
pubmed: 15654603
Diabetologia. 2002 Oct;45(10):1353-61
pubmed: 12378375
Mucosal Immunol. 2020 Jan;13(1):12-21
pubmed: 31740744
Diabetes Care. 2015 Oct;38(10):1964-74
pubmed: 26404926
J Clin Microbiol. 1999 May;37(5):1288-93
pubmed: 10203472
Clin Chem. 2019 Sep;65(9):1141-1152
pubmed: 31409598
Curr Diab Rep. 2019 Aug 10;19(9):82
pubmed: 31401790
Nat Med. 2019 Dec;25(12):1865-1872
pubmed: 31792456
J Infect Dis. 2003 May 15;187(10):1562-70
pubmed: 12721936
Pediatr Diabetes. 2016 Jul;17 Suppl 22:8-16
pubmed: 27411431
Pediatr Diabetes. 2013 May;14(3):149-58
pubmed: 23517503
Pediatr Diabetes. 2016 Jul;17 Suppl 22:56-64
pubmed: 27411438
Diabetologia. 2003 Aug;46(8):1100-5
pubmed: 12845430
Pediatrics. 2007 May;119(5):941-6
pubmed: 17473095
Clin Exp Immunol. 1985 Apr;60(1):139-44
pubmed: 4006299
Discov Med. 2010 Aug;10(51):151-60
pubmed: 20807476
Diabetes Care. 2015 Jan;38 Suppl:S8-S16
pubmed: 25537714
Tissue Antigens. 2008 Nov;72(5):425-30
pubmed: 18764813
J Med Virol. 2004 Apr;72(4):610-7
pubmed: 14981763
Tissue Antigens. 2003 Aug;62(2):162-9
pubmed: 12889996
Sci Rep. 2019 Feb 11;9(1):1749
pubmed: 30741981
Nat Rev Endocrinol. 2022 Aug;18(8):503-516
pubmed: 35650334
Clin Chim Acta. 2021 Apr;515:73-79
pubmed: 33422493
Front Endocrinol (Lausanne). 2021 Sep 07;12:706964
pubmed: 34557158
J Med Virol. 2003 Jan;69(1):91-8
pubmed: 12436483
Trends Endocrinol Metab. 2021 May;32(5):295-305
pubmed: 33712367
Hum Immunol. 2014 Jan;75(1):65-70
pubmed: 24055898
Scand J Immunol. 2014 Oct;80(4):283-92
pubmed: 24965593
Diabetes Technol Ther. 2007 Oct;9(5):460-72
pubmed: 17931054
Lancet. 2018 Jun 16;391(10138):2449-2462
pubmed: 29916386
Microorganisms. 2020 Jun 26;8(6):
pubmed: 32604930
Hum Vaccin. 2011 Sep;7(9):966-71
pubmed: 21860257
Viral Immunol. 2015 Dec;28(10):556-63
pubmed: 26485223
World J Diabetes. 2017 Jul 15;8(7):330-336
pubmed: 28751955
Viral Immunol. 2016 Sep;29(7):389-97
pubmed: 27482829
Expert Rev Vaccines. 2018 Dec;17(12):1071-1083
pubmed: 30449209

Auteurs

Kristi Alnek (K)

Department of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.

Ija Talja (I)

Department of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.

Brita Laht (B)

Department of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.

Kaja Metsküla (K)

Department of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.

Maire Mandel (M)

Department of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.

Ingrid Reppo (I)

Department of Internal Medicine, Institute of Clinical Medicine, University of Tartu, 8 L. Puusepa, Tartu 50406, Estonia.
Internal Medicine Clinic of Tartu University Hospital, 8 L. Puusepa, Tartu 50406, Estonia.

Maire Lubi (M)

Department of Internal Medicine, Institute of Clinical Medicine, University of Tartu, 8 L. Puusepa, Tartu 50406, Estonia.
Internal Medicine Clinic of Tartu University Hospital, 8 L. Puusepa, Tartu 50406, Estonia.

Raivo Uibo (R)

Department of Immunology, Institute of Bio- and Translational Medicine, University of Tartu, 19 Ravila, Tartu 50411, Estonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH